ReproCELL Inc.

In News

Price to sales forward of ReproCELL Inc. – TSE:4978 - TradingView

TradingView - Jun 29, 2026

REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6) - PR Newswire

PR Newswire - Jun 24, 2026

Top news this morning! ★ Keep an eye on ReproCELL, Polaris Holdings, and JX Metals! - Moomoo

Moomoo - Jun 24, 2026

REPROCELL Receives Commercialization Award from Maryland Stem Cell Research Fund to Advance Universal, Hypoimmune iPSC Platforms | Newswise - Newswise

Newswise - Jun 09, 2026

REPROCELL Receives Commercialization Award from Maryland Stem Cell Research Fund to Advance Universal, Hypoimmune iPSC Platforms - AOL.com

AOL.com - Jun 09, 2026

Major Shareholder Reprocell (5.81%) Heights Capital Management - Moomoo

Moomoo - Jun 17, 2026

REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed Editing Tools | Newswise - Newswise

Newswise - Jan 28, 2026

REPROCELL’s Clinical-Grade iPSCs: Advancing Cell Therapy - BioInformant

BioInformant - Mar 12, 2025

Induced Pluripotent Stem Cells Market Size to Hit USD 5.57 Billion by 2035 - Precedence Research

Precedence Research - Aug 01, 2025

Maryland Stem Cell Research Fund Awards $4.7 million to Support Innovations in Stem Cell Research - PR Newswire

PR Newswire - Oct 02, 2025

Steminent Announces Japan partner ReproCELL has PMDA Approval of CTN for Phase II Trial of Stemchymal® SCA in the Treatment of Spinocerebellar Ataxia in Japan - BioInformant

BioInformant - Aug 07, 2018

Glen Research names BioServe Biotechnologies as distributor for India - BioSpectrum India

BioSpectrum India - Aug 14, 2019

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment